Home      Tickers | SPY | NQ100 | DOW | Global | ETFs | Sector ETFs | 3x ETFs | ETF Movers | Stock Movers | Trading Alerts
     ^  ADMS:  Intraday  Hourly  Forecast  Similar  Waves  GapOpen  Research  Timing  Gains  Losses  Strategies  Practice
     Wed. Aug. 12, 2020

Trading Signals: ADMS Stock Price Prediction and Forecast (Thu. Apr. 10, 2014 - Mon. Aug. 9, 2021)

(Adamas Pharmaceuticals Inc)

Market is closed on Wed. Aug. 12, 2020


Trend Analysis and Forecast
 
Average Daily Percentage Swing  0% (three month average)
RSI   
Latest Price   $(0%)
Stocks Behave Similarly  Similar Stock List
Market Behavior  Broad based rally for large cap. Growth stock rally for small cap.
Correlated ETFs  Broad market will support ADMS advance at 0% a week (0% probability)
  VCSH(83%)    TIP(31%)    BND(30%)    BWX(25%)    VIXM(24%)  
Factors Impacting ADMS price  ADMS will advance at least -0% in a week (0% probabilities).
  SPY(-37%)    DIA(-36%)    XLB(-35%)    IVE(-33%)    XLK(-31%)  
 
 
Relative Volatility  
 
Market Trend Strength  0% (StdDev 0%)
Hourly BBV   0.1 ()
Intraday Trend   NAN%
  
 

  

Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA.

$. ADMS price fluctuates within NAN% (three month std-dev: 0%) daily (68% of days).

getNextHourMoveProbability failed